All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| STML / Stemline Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RCPT / Receptos, Inc.
|
|
|
|
|
|
|
|
| XNPT / XenoPort, Inc.
|
|
|
|
|
|
|
|
| CBST /
|
|
|
|
|
|
|
|
| 76028H209 / Repros Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF
|
|
|
|
|
|
|
|
| VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
| OCRX / Ocera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLXP / Salix Therapeuticals, Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| BIB / ProShares Trust - ProShares Ultra Nasdaq Biotechnology
|
|
|
|
|
|
|
|
| XOMA / XOMA Royalty Corporation
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NPSP / NPS Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| GEVA / Synageva Biopharma Corp
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ARROWHEAD RESEARCH CORP CMN
/ (042797209) |
|
|
|
|
|
|
|
| MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
| / Array BioPharma, Inc.
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US0153511094 / Alexion Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| ACRX / Talphera, Inc.
|
|
|
|
|
|
|
|
| US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CPHD / Cepheid
|
|
|
|
|
|
|
|
| HOLX / Hologic, Inc.
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CMRX / Chimerix, Inc.
|
|
|
|
|
|
|
|
| QGEN / Qiagen N.V.
|
|
|
|
|
|
|
|
| PCYC / Pharmacyclics
|
|
|
|
|
|
|
|
| PCYC / Pharmacyclics Call
|
|
|
|
|
|
|
|
| HGEN / Humanigen, Inc.
|
|
|
|
|
|
|
|
| MTD / Mettler-Toledo International Inc.
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| EXAS / Exact Sciences Corporation Put
|
|
|
|
|
|
|
|
| SGEN / Seagen Inc
|
|
|
|
|
|
|
|
| TECH / Bio-Techne Corporation
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc. Call
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| REGN / Regeneron Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CELG / Celgene Corp.
|
|
|
|
|
|
|
|
| IONS / Ionis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation Call
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc. Call
|
|
|
|
|
|
|
|
